Lessee, Operating Lease, Liability, to be Paid, Year Four in USD of Trevi Therapeutics, Inc. from Q4 2019 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Trevi Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four history and change rate from Q4 2019 to Q4 2024.
  • Trevi Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Four for the quarter ending 31 Dec 2024 was $95K, a 74.8% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Four, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Four, YoY Quarterly Change (%)

Trevi Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $95K -$282K -74.8% 31 Dec 2024 10-K 18 Mar 2025
Q3 2024 $95K -$282K -74.8% 30 Sep 2024 10-Q 06 Nov 2024
Q2 2024 $95K -$282K -74.8% 30 Jun 2024 10-Q 08 Aug 2024
Q1 2024 $95K -$282K -74.8% 31 Mar 2024 10-Q 07 May 2024
Q4 2023 $377K 31 Dec 2023 10-K 20 Mar 2024
Q3 2023 $377K 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 $377K 30 Jun 2023 10-Q 10 Aug 2023
Q1 2023 $377K 31 Mar 2023 10-Q 11 May 2023
Q2 2020 $24K 30 Jun 2020 10-Q 13 Aug 2020
Q1 2020 $24K 31 Mar 2020 10-Q 07 May 2020
Q4 2019 $24K 31 Dec 2019 10-K 16 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.